Tissue transfer processors segment by product is estimated to lead the market growth during the forecast period
According to a new market research study of “Asia Pacific Tissue Processing Systems Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product, Volume, End User and Country.” The Asia Pacific tissue processing systems market is expected to reach US$ 76.29 million in 2027 from US$ 49.58 million in 2019. The market is estimated to grow with a CAGR of 5.7% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific tissue processing systems market and the factors driving market along with those that act as hindrances.
By product, is segmented into tissue transfer processors and fluid transfer processors. The fluid transfer processors segment held the largest share of the market in 2019, whereas the tissue transfer processors segment is anticipated to register the highest CAGR in the market during the forecast period. Tissue processing is used to prepare the tissue for microscopic analysis by putting the tissue in a tangible medium. Tissue processing helps provide skinny and high-quality slices mounted on the glass slides and properly stained to indicate normal and abnormal structures. Tissue processing systems are widely used in cancer diagnostic laboratories, where biopsy samples are processed for cancer diagnosis. The growing aging population, prone to chronic diseases such as cancer, drives the demand for regular diagnostic tests. For instance, according to the Chinese Journal of Cancer Research, an estimated 2,865,174 cancer deaths occurred in 2018, with 1,791,805 deaths occurring in males and 1,073,369 in females. Thus, increasing prevalence of cancer is likely to boost the demand for tissue processors to perform cancer diagnosis. Also, growing network of diagnostic laboratories across globe is likely to favor the growth of the market.
The growth of the Asia Pacific tissue processing systems market is attributed to key driving factors such as rising prevalence of cancer and increasing number of diagnostic laboratories across globe. However, high cost of cancer diagnostics is expected to restrict the market growth during the forecast period.
MiltenyiBiotec, Leica Biosystems Nussloch GmbH (Danaher) and BioGenex are among the leading companies operating in the Asia Pacific tissue processing systems market.
The report segments in Asia Pacific Tissue Processing Systems Market as follows:
By Product
By Volume
By End User
By Country
Reasons to Buy
According to a new market research study of “Asia Pacific Tissue Processing Systems Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product, Volume, End User and Country.” The Asia Pacific tissue processing systems market is expected to reach US$ 76.29 million in 2027 from US$ 49.58 million in 2019. The market is estimated to grow with a CAGR of 5.7% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific tissue processing systems market and the factors driving market along with those that act as hindrances.
By product, is segmented into tissue transfer processors and fluid transfer processors. The fluid transfer processors segment held the largest share of the market in 2019, whereas the tissue transfer processors segment is anticipated to register the highest CAGR in the market during the forecast period. Tissue processing is used to prepare the tissue for microscopic analysis by putting the tissue in a tangible medium. Tissue processing helps provide skinny and high-quality slices mounted on the glass slides and properly stained to indicate normal and abnormal structures. Tissue processing systems are widely used in cancer diagnostic laboratories, where biopsy samples are processed for cancer diagnosis. The growing aging population, prone to chronic diseases such as cancer, drives the demand for regular diagnostic tests. For instance, according to the Chinese Journal of Cancer Research, an estimated 2,865,174 cancer deaths occurred in 2018, with 1,791,805 deaths occurring in males and 1,073,369 in females. Thus, increasing prevalence of cancer is likely to boost the demand for tissue processors to perform cancer diagnosis. Also, growing network of diagnostic laboratories across globe is likely to favor the growth of the market.
The growth of the Asia Pacific tissue processing systems market is attributed to key driving factors such as rising prevalence of cancer and increasing number of diagnostic laboratories across globe. However, high cost of cancer diagnostics is expected to restrict the market growth during the forecast period.
MiltenyiBiotec, Leica Biosystems Nussloch GmbH (Danaher) and BioGenex are among the leading companies operating in the Asia Pacific tissue processing systems market.
The report segments in Asia Pacific Tissue Processing Systems Market as follows:
By Product
- Tissue transfer processors
- Fluid transfer processors
By Volume
- Small volume processors
- Medium volume processors
- Large volume processors
By End User
- Hospitals
- Pharmaceutical companies
- Research laboratories
- Others
By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Reasons to Buy
- Determine prospective investment areas based on a detailed trend analysis of the Asia Pacific tissue processing systems market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Asia Pacific tissue processing systems market , providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific tissue processing systems market.
Table of Contents
1. Introduction
3. Research Methodology
4. Asia Pacific Tissue Processing Systems - Market Landscape
5. Tissue Processing Systems Market - Key Market Dynamics
6. Tissue Processing Systems Market - Asia Pacific Analysis
7. Tissue Processing Systems Market Analysis - By Product
8. Tissue Processing Systems Market Analysis - By Volume
9. Tissue Processing Systems Market Analysis - By End User
10. Tissue Processing Systems Market Revenue and Forecasts to 2027 - Asia Pacific Analysis
11. Impact of COVID-19 Pandemic on Asia Pacific Tissue Processing System Market
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Miltenyi Biotec
- BioGenex
- Leica Biosystems Nussloch GmbH (Danaher)
- Avantor, Inc.
- THERMO FISHER SCIENTIFIC INC.
- Siemens AG
- F. HOFFMANN-LA ROCHE LTD
- Agilent Technologies, Inc
